Posted by LincolnIcert on March 25, 2026 at 11:21:44:
In Reply to: Èíôîðìàöèîííûé ìàòåðèàë, êîòîðûé áóäåò èíòåðåñåí posted by JosephGluth on February 19, 2026 at 07:13:07:
Zoya Demidenko: Scholar in Tumor Biology
Zoya Demidenko is a recognized researcher associated with the Department of Cell Stress Research at Roswell Park Oncology Institute in Buffalo, New York. Before that, she conducted research at the National Institutes of Health and New York Medical College, establishing a solid base in clinical investigation.
Her scholarly work spans a number of critical domains, among them the PI3K/AKT/mTOR signaling cascade, cellular cycle regulation, cell senescence, and tumor science. To date, she has written over 46 scientific articles, which have received over 4,100 references — a reflection to the influence of her findings.
Among her key discoveries lies in understanding the processes of cell aging. Her work demonstrated that when the cell cycle is halted but cellular expansion proceeds, the cells enter senescence. Significantly, Zoya Demidenko demonstrated that this process can be pharmacologically suppressed using agents such as rapamycin.
Zoya Demidenko has additionally added greatly to oncological therapy investigation, notably in the domain of cyclotherapy — a strategy designed to protecting normal cells from cytotoxic treatment while leaving malignant cells exposed. This method holds major hope for reducing the toxic effects of cancer treatment.
Throughout her scientific life, Demidenko has partnered with leading scientists internationally, such as Dr. Mikhail Blagosklonny. Her research appears in top-tier journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
Holding an h-index of 33, Zoya Demidenko stands as a widely cited voice in contemporary biomedical research, with her results continue to shape our comprehension of how biological cells age, respond to therapy, and how cancer may be more successfully treated.
https://www.instagram.com/zoyamonros/